Mydecine Announces MYCO-005 Family of Improved Safety Microdose Novel Molecules

atai Impact Donates to the Multidisciplinary Association for Psychedelic Studies (MAPS)...

Psyched Wellness Announces Key Findings from the 90-Day Oral Toxicity Study...

BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity in Preclinical Model

PT293 – Stanislav & Brigitte Grof – The Evolution of Breathwork...

Psychedelic Bulletin: Mindstate Design Labs Leaves Stealth Mode; No Synthetic Psilocybin...

Cybin Inc. Reports Third Quarter Financial Results and Recent Business Highlights

PT292 – Sam Gandy – Vital Psychedelic Conversations

Psyence Group Announces DTC Eligibility Approval in the U.S.

Cybin Announces Grant of U.S. Patent Covering its Proprietary Compound CYB004...

Load more